Helix Biopharma: Fiscal Q1 Earnings Snapshot
Helix Biopharma: Fiscal Q4 Earnings Snapshot
Will present new preclinical data on L-DOS47 in combination with PD1 checkpoint inhibition at the 2023 ...
Helix Biopharma: Fiscal Q3 Earnings Snapshot
Helix Biopharma: Fiscal Q2 Earnings Snapshot
Helix Biopharma: Fiscal Q1 Earnings Snapshot
VANCOUVER, BC / ACCESSWIRE / April 22, 2022 / Mr. Jerzy Wilczewski announces the acquisition of 7,700,000 common shares ("Common Shares") in the capital of Helix Biopharma Corp. ("Helix" or the "Company")...
RICHMOND HILL, ON / ACCESSWIRE / April 21, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology,...
Is pleased to provide a corporate update on initiatives that were undertaken by the Company in 2021. ...
Provided a corporate update on initiatives that were undertaken by the Company in 2021. Despite the ...